<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">71569</article-id><article-id pub-id-type="doi">10.7554/eLife.71569</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-244135"><name><surname>Renaud</surname><given-names>Gabriel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244136"><name><surname>Nørgaard</surname><given-names>Maibritt</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244137"><name><surname>Lindberg</surname><given-names>Johan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244138"><name><surname>Grönberg</surname><given-names>Henrik</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244139"><name><surname>De Laere</surname><given-names>Bram</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244140"><name><surname>Jensen</surname><given-names>Jørgen Bjerggaard</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244141"><name><surname>Borre</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244142"><name><surname>Andersen</surname><given-names>Claus Lindbjerg</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244143"><name><surname>Sørensen</surname><given-names>Karina Dalsgaard</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-244144"><name><surname>Maretty</surname><given-names>Lasse</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-243451"><name><surname>Besenbacher</surname><given-names>Søren</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1455-1738</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Health Technology</institution>, <institution>Technical University of Denmark</institution>, <addr-line><named-content content-type="city">Kongens Lyngby</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff2"><institution content-type="dept">Department of Molecular Medicine</institution>, <institution>Aarhus University</institution>, <addr-line><named-content content-type="city">Aarhus N</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff3"><institution content-type="dept">Department of Medical Epidemiology and Biostatistics</institution>, <institution>Karolinska Institute</institution>, <addr-line><named-content content-type="city">Stockholm</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff4"><institution content-type="dept">Department of Urology</institution>, <institution>Regional Hospital of West Jutland</institution>, <addr-line><named-content content-type="city">Holstebro</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff5"><institution content-type="dept">Department of Urology</institution>, <institution>Aarhus University Hospital</institution>, <addr-line><named-content content-type="city">Aarhus</named-content></addr-line>, <country>Denmark</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1030"><name><surname>Weigel</surname><given-names>Detlef</given-names></name><role>Reviewing editor</role><aff><institution>Max Planck Institute for Biology Tübingen</institution>, <country>Germany</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>lasse.maretty@clin.au.dk</email> (LM);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>besenbacher@clin.au.dk</email> (SB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>07</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e71569</elocation-id><history><date date-type="received"><day>23</day><month>06</month><year>2021</year></date><date date-type="accepted"><day>27</day><month>07</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Renaud et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Renaud et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-71569-v1.pdf"/><abstract><p>Sequencing of cell-free DNA (cfDNA) is currently being used to detect cancer by searching both for mutational and non-mutational alterations. Recent work has shown that the length distribution of cfDNA fragments from a cancer patient can inform tumor load and type. Here, we propose non-negative matrix factorization (NMF) of fragment length distributions as a novel and completely unsupervised method for studying fragment length patterns in cfDNA. Using shallow whole-genome sequencing (sWGS) of cfDNA from a cohort of patients with metastatic castration-resistant prostate cancer (mCRPC), we demonstrate how NMF accurately infers the true tumor fragment length distribution as an NMF component - and that the sample weights of this component correlate with ctDNA levels (r=0.75). We further demonstrate how using several NMF components enables accurate cancer detection on data from various early stage cancers (AUC=0.96). Finally, we show that NMF, when applied across genomic regions, can be used to discover fragment length signatures associated with open chromatin.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>The Independent Research Fund Denmark</institution></institution-wrap></funding-source><award-id>Sapere Aude Research Leader</award-id><principal-award-recipient><name><surname>Besenbacher</surname><given-names>Søren</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>The Danish Cancer Society</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sørensen</surname><given-names>Karina Dalsgaard</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>The Central Denmark Region Health Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sørensen</surname><given-names>Karina Dalsgaard</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007605</institution-id><institution>Aarhus Universitet</institution></institution-wrap></funding-source><award-id>Graduate School of Health</award-id><principal-award-recipient><name><surname>Nørgaard</surname><given-names>Maibritt</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006088</institution-id><institution>Direktør Emil C. Hertz og Hustru Inger Hertz Fond</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sørensen</surname><given-names>Karina Dalsgaard</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010358</institution-id><institution>KV Fonden</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sørensen</surname><given-names>Karina Dalsgaard</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010371</institution-id><institution>Raimond og Dagmar Ringgård-Bohns Fond</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sørensen</surname><given-names>Karina Dalsgaard</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution>Beckett Fonden</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sørensen</surname><given-names>Karina Dalsgaard</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004331</institution-id><institution>Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Fond</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sørensen</surname><given-names>Karina Dalsgaard</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The prostate study was approved by The National Committee on Health Research Ethics (#1901101) and notified to The Danish Data Protection Agency (#1-16-02-366-15). All patients provided written informed consent.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Danish law requires ethical approval of any specific research aim and imposes restrictions on sharing of personal data. This means that the prostate cancer data used in this article cannot be uploaded to international databases. External researchers (academic or commercial) interested in analysing the prostate dataset (including any derivatives of it) will need to contact the Data Access Committee via email to kdso@clin.au.dk. The Data Access Committee is formed of co-authors Karina Dalsgaard Sørensen and Michael Borre, and Ole Halfdan Larsen (Department Head Consultant, Department of Clinical Medicine, Aarhus University). Due to Danish Law, for the authors to be allowed to share the data (pseudonymised) it will require prior approval from The Danish National Committee on Health Research Ethics (or similar) for the specific new research goal. The author (based in Denmark) has to submit the application for ethical approval, with the external researcher(s) as named collaborator(s)). In addition to ethical approval, a Collaboration Agreement and a Data Processing Agreement is required, both of which must be approved by the legal office of the institution of the author (data owner) and the legal office of the institution of the external researcher (data processor). Raw fragment length distributions along with ctDNA% estimates are available in Supplementary File 1.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Stephen Cristiano</collab><collab>Alessandro Leal</collab><collab>Jillian Phallen</collab><collab>Jacob Fiksel</collab><collab>Vilmos Adleff</collab><collab>Daniel C. Bruhm</collab><collab>Sarah Østrup Jensen</collab><collab>Jamie E. Medina</collab><collab>Carolyn Hruban</collab><collab>James R. White</collab><collab>Doreen N. Palsgrove</collab><collab>Noushin Niknafs</collab><collab>Valsamo Anagnostou</collab><collab>Patrick Forde</collab><collab>Jarushka Naidoo</collab><collab>Kristen Marrone</collab><collab>Julie Brahmer</collab><collab>Brian D. Woodward</collab><collab>Hatim Husain</collab><collab>Karlijn L. van Rooijen</collab><collab>Mai-Britt Worm Ørntoft</collab><collab>Anders Husted Madsen</collab><collab>Cornelis J.H. van de Velde</collab><collab>Marcel Verheij</collab><collab>Annemieke Cats</collab><collab>Cornelis J.A. Punt</collab><collab>Geraldine R. Vink</collab><collab>Nicole C.T. van Grieken</collab><collab>Miriam Koopman</collab><collab>Remond J.A. Fijneman</collab><collab>Julia S. Johansen</collab><collab>Hans Jørgen Nielsen</collab><collab>Gerrit A. Meijer</collab><collab>Claus Lindbjerg Andersen</collab><collab>Robert B. Scharpf</collab><collab>and Victor E. Velculescu</collab></person-group><year iso-8601-date="2019">2019</year><source>Genome-wide cell-free DNA fragmentation in patients with cancer</source><ext-link ext-link-type="uri" xlink:href="https://ega-archive.org/datasets/EGAD00001005339">https://ega-archive.org/datasets/EGAD00001005339</ext-link><comment>EGA, EGAD00001005339</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-71569-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>